Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
COA / Lab results Evidence: Preclinical Pros Selective, membrane-permeable NNMT inhibitor Raises intracellular NAD+ and SAM by blocking the methylation sink Reduced weight and fat mass in diet-induced obese mice Activates sirtuin pathways associated with metabolic health Cons Evidence entirely preclinical (cell/mouse)
It can help support the appearance of mild unevenness and pigmentation over time, especially when paired with sunscreen and consistent use
Even when people discuss peptide therapy, many online products are not subject to the same level of regulation as prescription medicines
What makes your approach to medicine unique
Patients who are pregnant, nursing, under 18, or have active malignancies shouldn't use this combination
Not because it is the only device that can deliver GHK-Cu to the dermis, but because its design choices map cleanly onto the failure modes the literature has spent two decades pointing at
